204 related articles for article (PubMed ID: 30765169)
1. Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay.
Chae W; Kim P; Hwang BJ; Seong BL
Vaccine; 2019 Mar; 37(11):1457-1466. PubMed ID: 30765169
[TBL] [Abstract][Full Text] [Related]
2. Hemagglutinin Quantitative ELISA-based Potency Assay for Trivalent Seasonal Influenza Vaccine Using Group-Specific Universal Monoclonal Antibodies.
Chae W; Kim P; Kim H; Cheong YC; Kim YS; Kang SM; Seong BL
Sci Rep; 2019 Dec; 9(1):19675. PubMed ID: 31873147
[TBL] [Abstract][Full Text] [Related]
3. An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines.
Bodle J; Vandenberg K; Laurie K; Barr IG; Zhang Y; Rockman S
Front Immunol; 2023; 14():1147028. PubMed ID: 37033922
[TBL] [Abstract][Full Text] [Related]
4. Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
Verma S; Soto J; Vasudevan A; Schmeisser F; Alvarado-Facundo E; Wang W; Weiss CD; Weir JP
PLoS One; 2017; 12(4):e0175733. PubMed ID: 28423025
[TBL] [Abstract][Full Text] [Related]
5. Potency determination of inactivated H7 influenza vaccines using monoclonal antibody-based ELISA and biolayer interferometry assays.
Vasudevan A; Woerner A; Schmeisser F; Verma S; Williams O; Weir JP
Influenza Other Respir Viruses; 2018 Mar; 12(2):250-258. PubMed ID: 29152878
[TBL] [Abstract][Full Text] [Related]
6. Avian glycan-specific IgM monoclonal antibodies for the detection and quantitation of type A and B haemagglutinins in egg-derived influenza vaccines.
Legastelois I; Chevalier M; Bernard MC; de Montfort A; Fouque M; Pilloud A; Serraille C; Devard N; Engel O; Sodoyer R; Moste C
J Virol Methods; 2011 Dec; 178(1-2):129-36. PubMed ID: 21907241
[TBL] [Abstract][Full Text] [Related]
7. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines.
Schmeisser F; Vasudevan A; Soto J; Kumar A; Williams O; Weir JP
Influenza Other Respir Viruses; 2014 Sep; 8(5):587-95. PubMed ID: 25087462
[TBL] [Abstract][Full Text] [Related]
9. Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies.
Nakajima R; Supnet M; Jasinskas A; Jain A; Taghavian O; Obiero J; Milton DK; Chen WH; Grantham M; Webby R; Krammer F; Carter D; Felgner PL; Davies DH
mSphere; 2018 Dec; 3(6):. PubMed ID: 30541779
[TBL] [Abstract][Full Text] [Related]
10. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS
J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655
[TBL] [Abstract][Full Text] [Related]
11.
An Y; Parsons LM; Jankowska E; Melnyk D; Joshi M; Cipollo JF
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355697
[TBL] [Abstract][Full Text] [Related]
12. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
[TBL] [Abstract][Full Text] [Related]
13. Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza.
Manceur AP; Zou W; Marcil A; Paquet E; Gadoury C; Jaentschke B; Li X; Petiot E; Durocher Y; Baardsnes J; Rosa-Calatrava M; Ansorge S; Kamen AA
PLoS One; 2017; 12(6):e0180314. PubMed ID: 28662134
[TBL] [Abstract][Full Text] [Related]
14. Seasonal influenza vaccination is the strongest correlate of cross-reactive antibody responses in migratory bird handlers.
Oshansky CM; Wong SS; Jeevan T; Smallwood HS; Webby RJ; Shafir SC; Thomas PG
mBio; 2014 Dec; 5(6):e02107. PubMed ID: 25491354
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analyses of all influenza type A viral hemagglutinins and neuraminidases using universal antibodies in simple slot blot assays.
Gravel C; Li C; Wang J; Hashem AM; Jaentschke B; Van Domselaar G; He R; Li X
J Vis Exp; 2011 Apr; (50):. PubMed ID: 21490585
[TBL] [Abstract][Full Text] [Related]
16. An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection.
Ni Y; Guo J; Turner D; Tizard I
Front Immunol; 2018; 9():1815. PubMed ID: 30140267
[TBL] [Abstract][Full Text] [Related]
17. Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity.
Wen Y; Palladino G; Xie Y; Ferrari A; Settembre EC
Vaccine; 2018 May; 36(21):3010-3017. PubMed ID: 29680201
[TBL] [Abstract][Full Text] [Related]
18. Development and applications of universal H7 subtype-specific antibodies for the analysis of influenza H7N9 vaccines.
Gravel C; Elmgren C; Muralidharan A; Hashem AM; Jaentschke B; Xu K; Widdison J; Arnold K; Farnsworth A; Rinfret A; Van Domselaar G; Wang J; Li C; Li X
Vaccine; 2015 Feb; 33(9):1129-34. PubMed ID: 25620245
[TBL] [Abstract][Full Text] [Related]
19. Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings.
Wen Y; Palladino G; Xie Y; Ferrari A; Ma X; Han L; Dormitzer PR; Settembre EC
Vaccine; 2016 Jun; 34(29):3388-95. PubMed ID: 27154389
[TBL] [Abstract][Full Text] [Related]
20. Conformationally selective biophysical assay for influenza vaccine potency determination.
Wen Y; Han L; Palladino G; Ferrari A; Xie Y; Carfi A; Dormitzer PR; Settembre EC
Vaccine; 2015 Oct; 33(41):5342-5349. PubMed ID: 26348403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
